Preferred Label : B7-H1 Antigen;

MeSH definition : An inhibitory B7 antigen that has specificity for the T-CELL receptor PROGRAMMED CELL DEATH 1 PROTEIN. CD274 antigen provides negative signals that control and inhibit T-cell responses and is found at higher than normal levels on tumor cells, suggesting its potential role in TUMOR IMMUNE EVASION.; An inhibitory B7 antigen that contains V-type and C2 type immunoglobulin domains. It has specificity for the T-CELL receptor PROGRAMMED CELL DEATH 1 PROTEIN and provides negative signals that control and inhibit T-cell responses. It is found at higher than normal levels on tumor cells, suggesting its potential role in TUMOR IMMUNE EVASION.;

MeSH synonym : CD274 antigens; B7-H1 immune costimulatory protein; B7 H1 immune costimulatory protein; programmed cell death 1 ligand 1 protein; CD274 antigen; antigen, CD274; PD-L1 costimulatory protein; costimulatory protein, PD-L1; PD L1 costimulatory protein; programmed cell death 1 ligand 1; antigen, B7-H1; B7 H1 antigen; B7H1 immune costimulatory protein; Antigens, CD274; Programmed Death Ligand 1; PD-L1 Protein; PD L1 Protein;

Is substance : O;

Details


Main resources

You can consult :

An inhibitory B7 antigen that has specificity for the T-CELL receptor PROGRAMMED CELL DEATH 1 PROTEIN. CD274 antigen provides negative signals that control and inhibit T-cell responses and is found at higher than normal levels on tumor cells, suggesting its potential role in TUMOR IMMUNE EVASION.
An inhibitory B7 antigen that contains V-type and C2 type immunoglobulin domains. It has specificity for the T-CELL receptor PROGRAMMED CELL DEATH 1 PROTEIN and provides negative signals that control and inhibit T-cell responses. It is found at higher than normal levels on tumor cells, suggesting its potential role in TUMOR IMMUNE EVASION.

https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/posologie-des-anticorps-monoclonaux-ciblant-le-pd-1-ou-le-pd-l1.html
2023
false
false
false
Canada
programmed cell death 1 receptor
Nivolumab
pembrolizumab
antibodies, monoclonal, humanized
atezolizumab
avelumab
cemiplimab
durvalumab
guidelines for drug use
antibodies, monoclonal
antibodies, monoclonal
B7-H1 Antigen

---
https://pgtmsite.files.wordpress.com/2024/01/ad-pembro_rapport-final1.pdf
2022
Canada
drug information
neoplasm, malignant
quebec
pembrolizumab
carcinoma, non-small-cell lung
Nonmetastatic
CYRIB wt Allele
L1 Stage Finding
Metastatic
Daur Chinese
lupus erythematosus cell
Lower Esophageal Sphincter
Lung Non-Small Cell Carcinoma
metastatic to
L1 Mouse
small cell lung carcinoma
patients
Patient
has patient
LE cells
Due
Long Interspersed Nucleotide Element-1
Pembrolizumab
Identifier
Intent To Treat
Device-In-Use Domain
Metastatic Malignant Neoplasm
Deoxyuridine
B7-H1 Antigen
pembrolizumab
pembrolizumab
intention to treat analysis
Analysis
hospitals, university
neutrophils
Cancer Therapeutic Procedure
Analyzed
Description
INRG Stage L1

---
Nous contacter.
29/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.